Vimarsana
Biggest News Aggregation in the World

Page 2 - Thomas Ybert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Ybert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Ybert Today - Breaking & Trending Today

French Defense Innovation Agency Investigates the Use of DNA Script's SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats - Vimarsana News

French Defense Innovation Agency Investigates the Use of DNA Script's SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats

In response to strong results, the Agency has extended DNA Script's contract DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR

DNA Script Partners with Premas Life Sciences Pvt. Ltd., India as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis - Vimarsana News

DNA Script Partners with Premas Life Sciences Pvt. Ltd., India as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis

New Delhi [India], May 5 (ANI/NewsVoir): DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached a distribution agreement with Premas Life Sciences Pvt Ltd, India, a leading biotechnology distribution company

Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service - Vimarsana News

Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service

The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.

DNA Script launches early access program for latest advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology - Vimarsana News

DNA Script launches early access program for latest advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology

DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the launch of a new program for customers of their SYNTAX System, in which organizations receive early access to the latest advancements of their EDS technology. Dubbed the DNA Scriptors Early Access Program, its members already include the London Biofoundry and the BASE facility at the University of Queensland (UQ), Australia. 

DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology - Vimarsana News

DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology

Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin. DNA Script, a world leader in